65
Participants
Start Date
January 15, 2021
Primary Completion Date
October 23, 2023
Study Completion Date
October 23, 2023
Acapatamab
Acapatamab will be administered as an intravenous (IV) infusion.
Enzalutamide
Enzalutamide will be administered orally.
Abiraterone
Abiraterone will be administered orally.
AMG 404
AMG 404 will be administered as an intravenous (IV) infusion.
St Vincents Hospital Sydney, Darlinghurst
Rigshospitalet, København Ø
Clinica Universidad de Navarra, Pamplona
University of Alabama at Birmingham, Birmingham
Norton Cancer Institute, Louisville
University of Chicago, Chicago
Akademiska sjukhuset, Uppsala
University of Texas Southwestern Medical Center, Dallas
University of Texas MD Anderson Cancer Center, Houston
University of California at Irvine Medical Center, Orange
University of California San Francisco Mission Bay Campus, San Francisco
Skanes universitetssjukhus, Lund
Karolinska Universitetssjukhuset Solna, Stockholm
Royal Marsden Hospital, Sutton
Lead Sponsor
Amgen
INDUSTRY